Macromoltek
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
Y Combinator
yc-company-directory #3912Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
sourceMacromoltek is classified as Developer tools from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to Macromoltek
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Nabla Bio
match 69Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.
shared extracted concept terms: biotech, antibody; shared product terms: antibody, design, enable, target; shared affiliation: Y Combinator
Orbion
match 44Orbion helps pharmaceutical and biotech companies accelerate their drug discovery process with its proprietary AI models.
shared extracted concept terms: biotech, proprietary; shared product terms: drug, proprietary, biotech
Felix Biotechnology
match 27We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.
shared extracted concept terms: design; shared product terms: design, against; shared affiliation: Y Combinator
Agentnoon
match 27🚀 Enable strategic decision making using a fast, flexible, and intuitive org design and workforce planning platform. ⚡
shared extracted concept terms: design; shared product terms: enable, design; shared affiliation: Y Combinator
TruSpin Nanomaterial Innovation
match 26TruSpin is an advanced materials company using a proprietary technique to mass-produce new types of nanofibers.
shared extracted concept terms: proprietary; shared product terms: proprietary, produce
Aradon
match 26Aradon makes biotech robot labs easy to install and operate for scientists. Removing the manual work bottleneck from biotech will enable new medical solutions and enhance healthcare globally.
shared extracted concept terms: biotech; shared product terms: biotech, enable